3D mammograms & Gen-Probe products insure bright future for HOLX
Hologic continued to witness revenue growth on the back of inclusion of Gen-Probe revenues, higher sales of MyoSure and tomosynthesis systems and wider installed base of digital mammography systems. The APTIMA STD line has been a major growth catalyst over the past few quarters.
As per management, tests menu expansion on the PANTHER systems presents another upside. The company is also banking on its innovative 3D tomosysnthesis technology to drive revenues over the long haul.